Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 25, 1997

View Archived Issues

Draxis Health: Q3 1997 highlights

GalaGen: Q3 1997 highlights

GelTex: Q3 1997 highlights

Novartis: Q3 1997 highlights

OraVax: Q3 1997 highlights

HMR and Scriptgen enter antifungal drug discovery alliance

Cytokine combination demonstrates antiinfective activity in mice

Toray/Daiichi to begin clinical development of non-narcotic analgesic

Techniclone reacquires rights to Oncolym

Axiom, Zaiya and Nippon Kagaku anticancer drug discovery alliance

Dainippon's aldose reductase inhibitor in preclinical testing

Anika signs Orthovisc marketing agreement with Zimmer

Daiichi synthesizes paclitaxel derivatives

BioChem Pharma patents agents for CMV

Muscarinic cholinergic agonists disclosed by Novo Nordisk

SKB describes novel 5-HT1B antagonists

Novel beta-agonists for obesity and diabetes described by SmithKline Beecham

Dual CysLT1/H1 receptor antagonists described in patent literature

Sankyo discloses inositol 1,4,5-triphosphate inhibitors

DNA-intercalating agents reported by Mitsui Toatsu in patent literature

Spotlight on carbonic anhydrase inhibitors for glaucoma

New valproic acid analogue selected as candidate anticonvulsant

Synthelabo's Solian introduced in U.K.

Fixed-dose trandolapril/verapamil combination now available in U.K.

German launch for Eisai/Pfizer Alzheimer's Rx

Bayer introduces statin in Germany

CP-101606 evaluated in cat model of occlusive stroke

FDA approves sibutramine for the treatment of obesity

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

FR-127519: new CCK-A antagonist assessed in functional model

Agrylin approved in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...